A Pan-cancer Analysis of the Expression and Clinical Relevance of Small Nucleolar RNAs in Human Cancer

Jing Gong1, Yajuan Li2, Chun-Jie Liu3

  • 1Department of Biochemistry and Molecular Biology, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Department of Epidemiology and Biostatistics, Key Laboratory of Environmental Health of Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PRC.

Cell Reports
|November 16, 2017
PubMed

Insights

Small nucleolar RNAs (snoRNAs) are elevated in many cancers and linked to tumor subtypes. SNORD46 promotes cancer cell growth and invasion, highlighting snoRNAs as potential cancer biomarkers and therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Small nucleolar RNAs (snoRNAs) are increasingly recognized for their roles in cancer development.
  • Understanding the expression and function of snoRNAs in diverse cancer types is crucial for identifying new therapeutic strategies.

Purpose of the Study:

  • To systematically investigate the expression landscape and clinical relevance of snoRNAs across 31 cancer types using The Cancer Genome Atlas (TCGA) data.
  • To explore the regulatory mechanisms of snoRNA expression and their association with molecular and clinical cancer subtypes.
  • To identify clinically relevant snoRNAs and experimentally validate their functional roles in cancer progression.

Main Methods:

  • Analysis of >10,000 cancer samples from TCGA for snoRNA expression.
  • Investigation of regulatory factors including host gene expression, copy number variation, and DNA methylation.
  • Unsupervised clustering of snoRNA expression data to identify subtypes.
  • Experimental validation of SNORD46 function in cancer cell proliferation, migration, and invasion.

Main Results:

  • Elevated expression of snoRNAs and their ribonucleoproteins was observed in multiple cancer types.
  • snoRNA expression is complexly regulated by host genes, copy number variation, and DNA methylation.
  • snoRNA expression subtypes strongly correlated with existing molecular and clinical cancer subtypes.
  • 46 clinically relevant snoRNAs were identified, with SNORD46 experimentally shown to promote cancer cell proliferation, migration, and invasion.

Conclusions:

  • snoRNAs play significant roles in tumorigenesis and cancer progression.
  • snoRNA expression patterns can serve as valuable biomarkers for cancer classification and prognosis.
  • Targeting snoRNAs, such as SNORD46, may offer novel therapeutic strategies for cancer treatment.
  • The developed SNORic data portal provides a valuable resource for the cancer research community.

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.5K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K